Anna Hagen

Anna Hagen is a Clinical Research Associate at Bolt Biotherapeutics, Inc., beginning in July 2023, after serving as a Senior Clinical Trials Associate at Seagen from June 2022 to July 2023. Prior experience includes a role as a Clinical Trials Associate at Silverback Therapeutics from September 2021 to April 2022 and Project Coordinator at Fred Hutch from June 2016 to September 2021, where involvement in clinical trial management was significant. Additional roles include Program Assistant III and Office Assistant at Twin Harbors Eye Center and Grays Harbor College Learning Center, respectively. Educational qualifications include a Bachelor's degree in Medical Anthropology & Global Health and Human Evolutionary Biology from the University of Washington, along with an Associate of Arts degree from Grays Harbor College.